Liquid Biopsy Market Outlook, Opportunity and Demand Analysis, Forecast 2021 - 2028

 Analysis of the Global Liquid Biopsy Market

The latest report, Liquid Biopsy market enables stakeholders to gain insights into their potential consumers to construct more effective marketing strategies for the forecast period, 2021 to 2028. Most importantly, the document empowers business owners to seek information about potential consumers and where they can find them. With an exclusive coverage of the top vendors, the study enables business owners to know more about the local market and locate potential consumers.

Research on liquid biopsy has expanded recently, generating an entirely new field of study. Both industry and academic researchers from various areas of expertise are working on developing, refining, and establishing clinical uses for liquid biopsy tests. For instance, InterVenn Biosciences announced completion of USD 201 million Series C financing in August 2021. The funding will be used to speed up development and commercialization of InterVenn’s Dawn, which is a liquid biopsy assay for immune checkpoint inhibitor response prediction.

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/liquid-biopsy-market

The report offers strategic recommendations to the key stakeholders and investors to help them ascertain maximum returns on their investments and formulate new strategic business plans. The report covers the estimation of key market players, emerging new players, and regional analysis to offer a better understanding of the Liquid Biopsy market.   

The comprehensive report addresses the following questions:

Which region is expected to dominate the market over the coming years?

Which application or end-user segment is anticipated to show significant growth over the projected timeline?

What is the impact of the COVID-19 pandemic on the overall market growth?

What are the macro- and micro-economic factors influencing the growth of the market?

What are the recent R&D and technological advancements in the Liquid Biopsy market?

Competitive Landscape:

Key market players operating in the global Liquid Biopsy market and studied in the report include Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Adaptive Biotechnologies, NeoGenomics Laboratories, Guardant Health, Inc., RainDance Technologies, Inc., Biocept, Inc., Qiagen N.V., Trovagene, Inc., and F. Hoffmann-La Roche Ltd.

Furthermore, the report supplies an in-depth understanding and insight into the leading manufacturers and players with a brief overview of their business. This section deals with the latest business moves, product launches, strategic collaborations, technological advancements, and profitable business ventures. The report also includes revenue estimations and CAGR of the Liquid Biopsy market in the coming years.

The global Liquid Biopsy market report includes a comprehensive analysis of the top players of the market and their market scope through advanced analytical tools. Tools such as Porter’s Five Forces Analysis, SWOT analysis, feasibility analysis, and investment return analysis are used to analyze their growth patterns and market scope for the forecast period of 2020-2027.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/34

Liquid Biopsy Market Segmentation:

The report further explores the segmentation of the market based on types, applications, and regions.

Emergen Research has segmented the global liquid biopsy market on the basis of product, circulating biomarkers, sample type, disease, application, end-use, and region:

Product Outlook (Revenue, USD Billion; 2018–2028)

• Assays Kits
• Instruments
• Services

Circulating Biomarkers Outlook (Revenue, USD Billion; 2018–2028)

• Circulating Tumor DNA (ctDNA)
• Circulating Tumor Cells (CTCs)
• Extracellular Vesicles (EVs)
• Cell-Free DNA (cfDNA)
• Other Circulating Biomarkers

Sample Type Outlook (Revenue, USD Billion; 2018–2028)

• Blood Sample based
• Urine Sample based
• Other Bio Fluids based

Disease Outlook (Revenue, USD Billion; 2018–2028)

• Oncology
  1. Breast Cancer
  2. Lung Cancer
  3. Prostate Cancer
  4. Colorectal Cancer
  5. Melanoma Cancer
  6. Other Cancers
• Non-cancer disease

Application Outlook (Revenue, USD Billion; 2018–2028)

• Early Cancer Screening
• Therapy Selection
• Treatment Monitoring
• Recurrence Monitoring Orthopedics

End-use Outlook (Revenue, USD Billion; 2018–2028)

• Hospitals and Physician Laboratories
• Reference Laboratories
• Academic and Research Centers
• Others

Regional Analysis:

According to the regional analysis, the market is segmented into the key geographical regions, including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The report further provides insight into the regions dominating the market and is expected to lead the market in the coming years. The report also discusses the growth rate and market size of each major region for the forecast period. It also covers production and consumption patterns, supply and demand dynamics, current and emerging trends, import/export, and the presence of key players in each region.

In-depth Regional Analysis Covers:

North America (U.S., Canada, Mexico)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Highlights of the TOC of the report:

Chapter 1: Market overview

Chapter 2: Global Liquid Biopsy market analysis

Chapter 3: Regional analysis of the Liquid Biopsy industry

Chapter 4: Market segmentation based on types and applications

Chapter 5: Revenue analysis based on types and applications

Chapter 6: Competitive landscape

Chapter 7: Market share analysis

Chapter 8: Drivers, Restraints, Challenges, and Opportunities

Chapter 9: Gross Margin and Price Analysis

Refer to ToC for more information on the chapters of the report.

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/34

Thank you for reading our report. For further queries or to request customization, please get in touch with us. Our team will ensure you get the report best suited for your needs.